HWAM
ICPT

Hennion & Walsh Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Hennion & Walsh Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-46,315
Closed -$859K – 887
2023
Q3 		$859K Buy
46,315
+21,878
+90% +$247K 0.05% 394
2023
Q2 		$270K Buy
+24,437
New +$340K 0.02% 687
2022
Q4 		– Sell
-76,984
Closed -$1.07M – 821
2022
Q3 		$1.07M Sell
76,984
-4,349
-5% -$70K 0.07% 306
2022
Q2 		$1.12M Sell
81,333
-27,651
-25% -$443K 0.07% 288
2022
Q1 		$1.77M Sell
108,984
-4,264
-4% -$66.8K 0.09% 240
2021
Q4 		$1.84M Sell
113,248
-23,472
-17% -$396K 0.09% 246
2021
Q3 		$2.03M Sell
136,720
-4,038
-3% -$64.6K 0.11% 239
2021
Q2 		$2.81M Buy
140,758
+5,544
+4% +$110K 0.15% 192
2021
Q1 		$3.12M Buy
+135,214
New +$3.77M 0.19% 147

Hennion & Walsh Asset Management's ICPT Position: Q4 2023 in Review

Hennion & Walsh Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 46,315 shares — an estimated $859K sold.

Hennion & Walsh Asset Management first reported a position in ICPT in Q1 2021 and held it in 9 quarters. The position peaked at $3.12M in Q1 2021. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Hennion & Walsh Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 46,315 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $859K.
  • Hennion & Walsh Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2021 and held it in 9 quarters.
  • Hennion & Walsh Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $3.12M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2023, filed 10 Jan 2024.